Article

Femtosecond laser provides option of thinner LASIK flaps

There has been a recent trend toward thinner flaps for LASIK to decrease the risk of corneal ectasia following surgery. Other advantages exist as well for patients undergoing thin-flap LASIK.

The IntraLase femtosecond (FS) laser was introduced in the United States byPulsion (now IntraLase) approximately 4 years ago after receiving FDA approval. The push toward "bladeless" LASIK has been slow but has gained some ground swell over the past year. Professional surveys of refractive surgeons in the United States, done by the American Society of Cataract and Refractive Surgery (ASCRS) and the ISRS/AAO, suggest that IntraLase market share was somewhere from 3% to 8% in late 2003 and growing.1,2

Standard deviation and range were less with the MMK, suggesting perhaps slightly better predictability of flap thickness with a blade cut versus a laser cut when comparing these two specific systems. However, I suspect that setting the FS laser to a thinner flap setting and cutting a flap at an average thickness closer to 110 µm would have yielded a lesser standard deviation and range comparable with that of the MMK.

The key here, however, is the thin flap. Thin flaps exhibit less standard deviation than thick flaps, whether they are cut with an MMK or a FS laser.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.